AstraZeneca Pharma India is planning to sell its 64-acre manufacturing facility in North Bengaluru for an estimated ₹3,400 crore, as part of a broader global strategy to streamline its manufacturing and supply chain network.
The asset, located in a prime growth corridor, has attracted interest from multiple developers and institutional players. The move aligns with the company’s ongoing efforts to optimise its global operations and unlock value from non-core assets.
Asset Details and Market Valuation
The land parcel is situated in one of Bengaluru’s rapidly developing northern zones, known for infrastructure-led growth and proximity to the airport corridor.
Key Highlights
- Land size: 64 acres
- Estimated deal value: ₹3,400 crore
- Approximate valuation: ₹53+ crore per acre
- Location: North Bengaluru prime corridor
- Current use: Pharmaceutical manufacturing facility
Market sources indicate that the asset has already drawn interest from leading players such as Sattva Group, Aurobindo Pharma, and RMZ, among others.
Transaction Snapshot
| Parameter | Details |
|---|---|
| Seller | AstraZeneca Pharma India |
| Land Parcel Size | 64 acres |
| Estimated Value | ₹3,400 crore |
| Location | North Bengaluru |
| Potential Buyers | Developers & Pharma Firms |
| Land Use Potential | Mixed-use / Industrial / Residential |
Strategic Shift and Buyer Interest
The company is reportedly looking to identify a buyer who could either continue manufacturing operations under contract or redevelop the land for commercial and residential purposes, subject to regulatory approvals.
The transaction is part of AstraZeneca’s global realignment strategy, where it is reviewing its manufacturing footprint and focusing on efficiency across markets.
Real Estate Impact: Prime Land Unlocks Development Potential
The potential sale is expected to have a notable impact on Bengaluru’s real estate market, particularly in the northern corridor.
Market Implications
- Release of large-scale land parcel for redevelopment
- Increased interest from institutional developers
- Potential rise in land prices in surrounding areas
- Expansion of mixed-use and commercial projects
North Bengaluru continues to attract investments due to infrastructure projects such as airport expansion, tech parks, and connectivity improvements.
Infrastructure and Growth Outlook
The location’s proximity to key developments—including business parks, logistics hubs, and upcoming infrastructure corridors—enhances its attractiveness for future projects. Such large land monetisation deals are increasingly shaping the next phase of urban expansion in Bengaluru.
Conclusion
AstraZeneca’s proposed ₹3,400 crore land sale in Bengaluru highlights a growing trend of strategic asset monetisation by global firms. The transaction is expected to unlock significant development potential in North Bengaluru, reinforcing the region’s status as a high-growth real estate destination.
Also Read: My Home Udyan Kollur Launched: 3,700+ Apartments Project Details & Latest Update
